Rikard Göran Fred

Rikard Göran Fred serves as an Assistant Professor within the Hansen Group at the University of Copenhagen's Faculty of Health and Medical Sciences. Based at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR), his research addresses critical metabolic and hepatic disorders through advanced molecular techniques.

His primary research interests focus on metabolic disease mechanisms, particularly non-alcoholic steatohepatitis (NASH), type 2 diabetes complications, and liver cirrhosis. Using single-cell transcriptomics and cellular characterization methods, he investigates molecular pathways in liver inflammation, muscle degeneration, and fibro-adipogenic processes. His work bridges fundamental cell biology with clinical applications in metabolic disorders.

Analysis of his recent publications reveals strong emphasis on translational research connecting cellular mechanisms to clinical outcomes. His studies frequently employ single-cell RNA sequencing to dissect disease pathways in NASH and diabetes-related muscle degeneration, while also designing clinical trials for cirrhosis management. Collaborations span hepatology, endocrinology, and regenerative medicine disciplines.

Dr. Fred operates within the Hansen Group at CBMR, a leading metabolic research center at the University of Copenhagen. His work integrates laboratory-based molecular research with clinical trial design, focusing on therapeutic interventions for metabolic diseases. Current projects include investigating statin efficacy in cirrhosis and characterizing cellular mechanisms in diabetic muscle complications.